TrialInternational orthopaedics2020

Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial.

Lu Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.